Figure 1.
Figure 1. Cumulative survival since transplantation. Overall survival of patients receiving infliximab for steroid-refractory acute GVHD (n = 21).

Cumulative survival since transplantation. Overall survival of patients receiving infliximab for steroid-refractory acute GVHD (n = 21).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal